| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder. | J Clin Psychiatry | 2005 | 1.61 |
| 2 | Escitalopram in the treatment of social anxiety disorder: randomised, placebo-controlled, flexible-dosage study. | Br J Psychiatry | 2005 | 1.50 |
| 3 | Efficacy and tolerability of escitalopram in 12- and 24-week treatment of social anxiety disorder: randomised, double-blind, placebo-controlled, fixed-dose study. | Depress Anxiety | 2004 | 0.98 |
| 4 | Discontinuation symptoms in depression and anxiety disorders. | Int J Neuropsychopharmacol | 2005 | 0.95 |
| 5 | Escitalopram in the treatment of social anxiety disorder: analysis of efficacy for different clinical subgroups and symptom dimensions. | Depress Anxiety | 2004 | 0.82 |